BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 13, 2004
View Archived Issues
Statins improve outcomes in heart failure patients
Read More
Tamsulosin improves symptoms and quality of life in patients with CP/CPPS
Read More
Antiobesity drug effective against prostate cancer
Read More
11beta-Hydroxysteroid dehydrogenase inhibitor improves metabolic syndrome features
Read More
Preference for tadalafil among patients with erectile dysfunction
Read More
Aletheon acquires Pretarget intellectual property from NeoRx
Read More
NeoRx acquires rights to AMD-473 from AnorMED
Read More
SkyePharma and Medeus Pharma enter European DepoMorphine agreement
Read More
Schering AG to transfer oxybutynin incontinence ring to Barr
Read More
Array BioPharma and Takeda enter new drug discovery collaboration
Read More
Enrollment under way in phase III Periostat MR study for adult periodontitis
Read More
MediGene extends clinical development of Polyphenon E to actinic keratosis
Read More
Nycomed to develop and commercialize Oxygent in Europe
Read More
Adventrx enters definitive agreement for sale of common stock
Read More
ActivX to characterize activity of Gilead compounds
Read More
Novel histamine H3 antagonists and their use as antiobesity agents
Read More
Chiron researchers claim new pyrrole-based GSK-3 inhibitors
Read More
New gossypol analogues and their use in cancer therapy reported by CNRS
Read More
Merck KGaA team presents novel inhibitors of factor Xa and other coagulation factors
Read More
Novel small molecule tubulin inhibitor by Zentaris
Read More
Karo Bio scientists identify new thyroid receptor-beta agonists
Read More
New P-selectin antagonists and their use covered by Yamanouchi patent
Read More
Enhanced tumor cytotoxicity with novel DNA-PK inhibitor
Read More
New glucocorticoid receptor modulators discovered at Boehringer Ingelheim
Read More
New MTP inhibitors in early development at Janssen
Read More
Novel Bcl-XL antagonist effective against chemoresistant cancers in vivo
Read More
Phase II study of Puricase for severe gout begins
Read More
Ipsen enters into licensing agreement for Auxilium's Testim
Read More
Indevus and Pliva enter U.S. copromotion deal for Sanctura
Read More
Japanese launch for Viread
Read More
Vela licenses late-stage molecule for depression from Otsuka
Read More
FASgen receives NCI grant to support study of FAS inhibitors
Read More